Drupal.behaviors.print = function(context) {window.print();window.close();}>
Epic Sciences Gets Phase II SBIR Grant for Lung Cancer Assay Development
January 24, 2013
Epic Sciences Gets Phase II SBIR Grant for Lung Cancer Assay Development
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Epic Sciences Developing CTC-based CDx with Drug Firms
August 15, 2012 / GenomeWeb Daily News
Kindstar to Offer Insight Genetics' ALK Lung Cancer Screening Test
June 1, 2012 / GenomeWeb Daily News
NIH Awards Lucigen $2.8M SBIR Grant for POC Influenza Test
May 23, 2012 / GenomeWeb Daily News
TriLink Receives $100,000 SBIR Grant
March 15, 2011 / GenomeWeb Daily News
Insight Genetics Wins $200K Contract from NCI
November 9, 2010 / GenomeWeb Daily News